FDA further restricts pain medication use in kids

April 21, 2017

U.S. regulators are strengthening warnings about the dangers of two types of powerful painkillers due to risks of slowed breathing and death.

The Food and Drug Administration said Thursday it is requiring makers of prescription versions of the medicines, codeine and , to change the products' labels to warn against giving them to under age 12, and to limit use in older children. The FDA also said breastfeeding women shouldn't take them because of possible harm to the baby.

Many of the products containing these drugs are only available by prescription, but several over-the-counter cough medicines contain codeine. The FDA urged parents to carefully read labels of nonprescription to avoid codeine and to consult a doctor or pharmacist if needed.

The agency in 2013 had warned against use of codeine and tramadol in children and adolescents to treat pain after surgery to remove tonsils.

On Thursday, FDA said that some children are at higher risk of harm from the medicines because they break down codeine and tramadol more rapidly than normal, which can cause dangerously high levels of the drugs in the blood.

That can cause symptoms such as low or shallow breathing, confusion and, in breastfeeding infants, trouble breastfeeding and limpness.

"They are powerful, effective medicines when they're used right. They can cause a lot of harm when they're not," said the FDA's Dr. Douglas Throckmorton during a conference call.

Throckmorton said that the agency was both increasing restrictions on the products' labels and issuing a warning to consumers and pediatricians because of new information and concerns about the drugs' risks.

The FDA has been reviewing the safety of codeine and tramadol for a few years, including combing through reports about patients harmed dating to 1969.

From then until May of 2015, the agency identified 24 deaths and 40 other cases of serious in children under 18 taking medicines containing . It also identified three deaths and six other cases of serious breathing problems reported between January 1969 and March 2016 in children taking tramadol.

Most of those cases occurred in children under 12, and some happened after just one dose of the .

Explore further: Codeine risky for kids after certain surgeries, FDA says

Related Stories

Codeine risky for kids after certain surgeries, FDA says

February 21, 2013
(HealthDay)—Children who are given codeine for pain relief after surgery to remove tonsils or adenoids are at risk for overdose and death, U.S. health officials said Thursday.

MDs strengthen advice against codeine for kids' coughs, pain

September 19, 2016
The American Academy of Pediatrics has strengthened its warnings about prescribing codeine for children because of reports of deaths and risks for dangerous side effects including breathing problems.

US warns about use of codeine in children

August 15, 2012
(AP) — The U.S. Food and Drug Administration warned physicians and caregivers on Wednesday about the risks of giving the pain reliever codeine to children who have just had surgery to treat obstructive sleep apnea.

Doctors issue warning over cough medicines that contain codeine

December 22, 2015
An article in the online journal BMJ Case Reports describes the first published case of confusional state in a healthy 14-year-old girl attributed to excessive consumption of over the counter cough medicine that contained ...

Tramadol associated with increased risk of hospitalization for hypoglycemia

December 8, 2014
The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report published online by JAMA ...

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.